ICAM1 and Parkinson disease: Moreover, the presence of ICAM-1 in reactive astrocytes was identified in patients with PD as well as in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys, a nonhuman primate model of PD [18].